Contact

All Stories

  1. Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?

    Article • Expert Opinion on Pharmacotherapy, June 2019, Taylor & Francis

    Prof Alessandra Lugaresi

  2. First-line disease-modifying drugs in relapsing–remitting multiple sclerosis: an Italian real-life multicenter study on persistence

    Article • Current Medical Research and Opinion, April 2018, Taylor & Francis

    Prof Alessandra Lugaresi

  3. Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy

    Article • Neurological Sciences, October 2016, Springer Science + Business Media

    Prof Alessandra Lugaresi

  4. Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis

    Article • Journal of the Neurological Sciences, July 2016, Elsevier

    Prof Alessandra Lugaresi, Augusto Fusco

  5. The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study

    Article • PLoS ONE, June 2016, PLOS

    Prof Alessandra Lugaresi

  6. Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2016, BMJ

    Prof Alessandra Lugaresi

  7. Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory

    Article • PLoS ONE, April 2016, PLOS

    Prof Alessandra Lugaresi

  8. Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study

    Article • Expert Opinion on Drug Delivery, February 2016, Informa Healthcare

    Prof Alessandra Lugaresi

  9. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients

    Article • BMC Neurology, October 2015, Springer Science + Business Media

    Prof Alessandra Lugaresi

  10. How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis

    Article • Expert Opinion on Drug Delivery, September 2015, Informa Healthcare

    Prof Alessandra Lugaresi

  11. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

    Article • Brain, September 2015, Oxford University Press (OUP)

    Prof Alessandra Lugaresi

  12. Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells

    Article • Journal of Neuroinflammation, August 2015, Springer Science + Business Media

    Prof Alessandra Lugaresi

  13. Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers

    Article • Journal of Clinical Psychology in Medical Settings, July 2015, Springer Science + Business Media

    Prof Alessandra Lugaresi

  14. Patient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations

    Article • PLoS ONE, June 2015, PLOS

    Prof Alessandra Lugaresi

  15. Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure

    Article • Health Expectations, April 2015, Wiley

    Prof Alessandra Lugaresi

  16. Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial

    Article • Current Controlled Trials in Cardiovascular Medicine, April 2015, Springer Science + Business Media

    Prof Alessandra Lugaresi, Augusto Fusco

  17. Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Article • Annals of Clinical and Translational Neurology, February 2015, Wiley

    Dr Tim Spelman, Dr Tomas Kalincik, Prof Alessandra Lugaresi

  18. An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis

    Article • Molecular BioSystems, January 2015, Royal Society of Chemistry

    Prof Alessandra Lugaresi

  19. Pharmacology and clinical efficacy of dalfampridine for treating multiple sclerosis

    Article • Expert Opinion on Drug Metabolism & Toxicology, December 2014, Informa Healthcare

    Prof Alessandra Lugaresi

  20. Unmet Needs of People with Severe Multiple Sclerosis and Their Carers: Qualitative Findings for a Home-Based Intervention

    Article • PLoS ONE, October 2014, PLOS

    Prof Alessandra Lugaresi

  21. Effect of Natalizumab treatment on circulating CD4+ CD62L+ T-cells in Multiple Sclerosis patients

    Article • Journal of Neuroimmunology, October 2014, Elsevier

    Prof Alessandra Lugaresi

  22. The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population

    Article • BMC Neurology, September 2014, Springer Science + Business Media

    Professor Dawn Langdon, Prof Alessandra Lugaresi

  23. Fostering adherence to injectable disease-modifying therapies in multiple sclerosis

    Article • Expert Review of Neurotherapeutics, August 2014, Informa Healthcare

    Prof Alessandra Lugaresi

  24. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

    Article • BMC Neurology, April 2014, Springer Science + Business Media

    Prof Alessandra Lugaresi, Dr. Francesco Saccà

  25. The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals

    Article • Journal of the Neurological Sciences, February 2014, Elsevier

    Prof Alessandra Lugaresi

  26. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

    Article • Neuropsychiatric Disease and Treatment, June 2013, Taylor & Francis

    Dr Eugenio Pucci, Prof Alessandra Lugaresi, daniela travaglini

  27. Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments

    Article • PLoS ONE, April 2013, PLOS

    Prof Alessandra Lugaresi

  28. Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis

    Article • PROTEOMICS, February 2013, Wiley

    Prof Alessandra Lugaresi

  29. Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study

    Article • Deutsche Zeitschrift für Nervenheilkunde, February 2013, Springer Science + Business Media

    Prof Alessandra Lugaresi

  30. Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study

    Article • Journal of Neurology, December 2012, Springer Science + Business Media

    Prof Alessandra Lugaresi

  31. RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence

    Article • Expert Opinion on Drug Delivery, December 2012, Informa Healthcare

    Prof Alessandra Lugaresi

  32. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

    Article • BMC Neurology, October 2012, Springer Science + Business Media

    Prof Alessandra Lugaresi

  33. Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients

    Article • International Journal of Molecular Sciences, October 2012, MDPI AG

    Professor Marcela Reale, Prof Alessandra Lugaresi

  34. Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

    Article • BMC Neurology, March 2012, Springer Science + Business Media

    Prof Alessandra Lugaresi

  35. Improving patient–physician dialog: commentary on the results of the MS Choices survey

    Article • Patient Preference and Adherence, February 2012, Taylor & Francis

    Professor Tjalf Ziemssen, Prof Alessandra Lugaresi

  36. Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial

    Article • Health Expectations, November 2011, Wiley

    Prof Alessandra Lugaresi

  37. Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis

    Article • Journal of Proteomics, November 2011, Elsevier

    Prof Alessandra Lugaresi

  38. Anxiety and depression in multiple sclerosis patients around diagnosis

    Article • Journal of the Neurological Sciences, August 2011, Elsevier

    Prof Alessandra Lugaresi

  39. Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients

    Article • Journal of Translational Medicine, January 2011, Springer Science + Business Media

    Prof Alessandra Lugaresi

  40. Protein profiling of Guillain–Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry

    Article • Neuroscience Letters, November 2010, Elsevier

    Prof Alessandra Lugaresi

  41. Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

    Article • BMC Neurology, April 2010, Springer Science + Business Media

    Prof Alessandra Lugaresi

  42. Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery

    Article • Journal of Proteomics, January 2010, Elsevier

    Prof Alessandra Lugaresi

  43. A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples

    Article • Journal of Proteomics, January 2010, Elsevier

    Prof Alessandra Lugaresi, Gian Marco Ghiggeri

  44. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?

    Article • Expert Opinion on Drug Delivery, July 2009, Informa Healthcare

    Prof Alessandra Lugaresi

  45. Hand dystonia secondary to cervical demyelinating lesion

    Article • Acta Neurologica Scandinavica, January 2009, Wiley

    Prof Alessandra Lugaresi

  46. Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone®)

    Article • Multiple Sclerosis Journal, July 2008, SAGE Publications

    Professor Marcela Reale, Prof Alessandra Lugaresi

  47. Safety and Tolerability in Relapsing-Remitting Multiple Sclerosis Patients Treated With High-Dose Subcutaneous Interferon-Beta by Rebiject Autoinjection Over a 1-Year Period

    Article • Clinical Neuropharmacology, May 2008, Wolters Kluwer Health

    Prof Alessandra Lugaresi

  48. ‘Psychic Akinesia’ following Carbon Monoxide Poisoning

    Article • European Neurology, February 2008, Karger Publishers

    Prof Alessandra Lugaresi

  49. Sleep Apneas, Convulsive Syncopes and Autonomic Impairment in Type I Arnold-Chiari Malformation

    Article • European Neurology, February 2008, Karger Publishers

    Prof Alessandra Lugaresi

  50. Extrapyramidal Syndrome and Depression Induced by Flunarizine

    Article • European Neurology, February 2008, Karger Publishers

    Prof Alessandra Lugaresi

  51. Cleavage of cystatin C is not associated with multiple sclerosis

    Article • Annals of Neurology, September 2006, Wiley

    Prof Alessandra Lugaresi

  52. Quasims: eine weltweite Beobachtungsstudie der Interferon-Beta Präparate in der Therapie der schubförmigen Multiplen Sklerose

    Article • Aktuelle Neurologie, October 2005, Thieme Publishing Group

    Prof Alessandra Lugaresi

  53. Demyelinating motor Guillain-Barre syndrome following rubella

    Article • Neurology, January 2005, Wolters Kluwer Health

    Prof Alessandra Lugaresi

  54. Gender related cognitive impairment in MS

    Article • Journal of Neurology, October 2004, Springer Science + Business Media

    Prof Alessandra Lugaresi

  55. IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors

    Article • Experimental Gerontology, April 2004, Elsevier

    Professor Marcela Reale, Prof Alessandra Lugaresi

  56. The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy

    Article • Annals of Neurology, January 2004, Wiley

    Prof Alessandra Lugaresi

  57. Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant

    Article • Neurology, September 2003, Wolters Kluwer Health

    Prof Alessandra Lugaresi

  58. Apolipoprotein E genotype does not influence the progression of multiple sclerosis

    Article • Journal of Neurology, September 2003, Springer Science + Business Media

    Prof Alessandra Lugaresi

  59. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

    Article • Clinical Neurophysiology, March 2002, Elsevier

    Prof Alessandra Lugaresi

  60. Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis

    Article • Journal of Neuroimmunology, February 2002, Elsevier

    Prof Alessandra Lugaresi, Professor Marcela Reale

  61. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

    Article • Journal of Neuroimmunology, July 2000, Elsevier

    Prof Alessandra Lugaresi, Professor Marcela Reale

  62. Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy

    Article • Journal of Neuroimmunology, March 1999, Elsevier

    Prof Alessandra Lugaresi

  63. Steroid-responsive multifocal demyelinating neuropathy with central involvement

    Article • Muscle & Nerve, February 1999, Wiley

    Prof Alessandra Lugaresi

  64. Effect of rhTNF-α injection into rat sciatic nerve

    Article • Journal of Neuroimmunology, February 1999, Elsevier

    Prof Alessandra Lugaresi

  65. Introduction

    Article • January 1999, Springer Science + Business Media

    Prof Alessandra Lugaresi

  66. RANTES and MCP-1 secretion by mononuclear cells of patients with multiple sclerosis

    Article • Journal of Neuroimmunology, September 1998, Elsevier

    Professor Marcela Reale, Prof Alessandra Lugaresi

  67. Interferon beta normalizes suppressor cell function in dysimmune neuropathies

    Article • Journal of Neuroimmunology, February 1998, Elsevier

    Prof Alessandra Lugaresi

  68. Letters to the editor

    Article • Muscle & Nerve, December 1996, Wiley

    Prof Alessandra Lugaresi

  69. Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder?

    Article • Muscle & Nerve, March 1996, Wiley

    Prof Alessandra Lugaresi

  70. Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder?

    Article • Muscle & Nerve, March 1996, Wiley

    Prof Alessandra Lugaresi

  71. Hand dystonia secondary to cervical demyelinating lesions: an electrophysiological study

    Article • Electroencephalography and Clinical Neurophysiology, September 1995, Elsevier

    Prof Alessandra Lugaresi

  72. Benign monomelic amyotrophy of lower limb: a rare entity with a characteristic muscular CT

    Article • Journal of the Neurological Sciences, November 1994, Elsevier

    Prof Alessandra Lugaresi

  73. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies

    Article • Muscle & Nerve, June 1993, Wiley

    Prof Alessandra Lugaresi

  74. Sclerosi multipla: Meccanismi patogenetici alla base della demielinizzazione

    Article • The Neuroradiology Journal, April 1993, SAGE Publications

    Prof Alessandra Lugaresi

  75. Basal ganglia involvement in multiple sclerosis with alternating side paroxysmal dystonia

    Article • Deutsche Zeitschrift für Nervenheilkunde, January 1993, Springer Science + Business Media

    Prof Alessandra Lugaresi

  76. Sympathetic skin response in hemispheric lesions

    Article • Neurophysiologie Clinique, December 1992, Elsevier

    Prof Alessandra Lugaresi

  77. Isolated Bovine Spinal Motoneurons Have Specific Ganglioside Antigens Recognized by Sera from Patients with Motor Neuron Disease and Motor Neuropathy

    Article • Journal of Neurochemistry, November 1992, Wiley

    Prof Alessandra Lugaresi

  78. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons

    Article • Annals of Neurology, October 1992, Wiley

    Prof Alessandra Lugaresi

  79. Anti-sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons

    Article • Journal of the Neurological Sciences, October 1992, Elsevier

    Prof Alessandra Lugaresi

  80. Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex

    Article • Clinical Autonomic Research, June 1992, Springer Science + Business Media

    Prof Alessandra Lugaresi, Professor Piero Parchi

  81. Idiopathic recurring stupor: A case with possible involvement of the gamma-aminobutyric acid (GABA)ergic system

    Article • Annals of Neurology, May 1992, Wiley

    Prof Alessandra Lugaresi

  82. Identification of glycoconjugates which are targets for anti-Gal(β1-3)GalNAc autoantibodies in spinal motor neurons

    Article • Journal of Neuroimmunology, October 1991, Elsevier

    Prof Alessandra Lugaresi

  83. F response in vascular and degenerative upper motor neuron lesions

    Article • Neurophysiologie Clinique, October 1990, Elsevier

    Prof Alessandra Lugaresi

  84. Diurnal variability in cranial dystonia

    Article • Movement Disorders, January 1990, Wiley

    Prof Alessandra Lugaresi

  85. Physiological hypnic myoclonus

    Article • Electroencephalography and Clinical Neurophysiology, August 1988, Elsevier

    Prof Alessandra Lugaresi

  86. Fasciculations during wakefulness and sleep

    Article • Acta Neurologica Scandinavica, August 1987, Wiley

    Prof Alessandra Lugaresi

  87. LACK OF VEGETATIVE AND ENDOCRINE ORCADIAN RHYTHMS IN FATAL FAMILIAL THALAMIC DEGENERATION

    Article • Clinical Endocrinology, May 1987, Wiley

    Prof Alessandra Lugaresi

  88. Fatal Familial Insomnia and Dysautonomia with Selective Degeneration of Thalamic Nuclei

    Article • New England Journal of Medicine, October 1986, New England Journal of Medicine (NEJM/MMS)

    Prof Alessandra Lugaresi

  89. Effect of oxygen radicals and hyperoxia on rat heart ornithine decarboxylase activity

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, October 1982, Elsevier

    Prof Alessandra Lugaresi